In patients with glioblastoma, the average survival time with current treatments is short,
mainly due to recurrences and resistance to therapy. This insufficient treatment success is, in …

Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor and
is characterized by high mortality and morbidity rates and unpredictable clinical behavior …

Background: Glioma is the most frequent primary tumor of the central nervous system. The
high heterogeneity of glioma tumors enables them to adapt to challenging environments …

Microglia, a type of differentiated tissue macrophage, are considered to be the most plastic
cell population of the central nervous system (CNS). Microglia substantially contribute to the …

COST Action CA17140 Cancer Nanomedicine—from the bench to the bedside
(Nano2Clinic,) is the first, pan-European interdisciplinary network of representatives from …

Glioblastoma (GB) is highly invasive and resistant to multimodal treatment partly due to
distorted vasculature and exacerbated inflammation. The aggressiveness of brain tumors …

Microglia serve as a front-line defense against neuroinvasive viral infection, however,
determination of their actual transcriptional profiles under conditions of health and disease is …

Allograft functional failure due to acute or chronic rejection has long been a major concern in
the area of solid organ transplantation for decades. As critical component of innate immune …

Immunotherapy has emerged as a powerful strategy for halting cancer progression.
However, primary malignancies affecting the brain have been exempt to this success …

Mapping the tumor-infiltrating immune cells during glioblastoma progression | Nature
Immunology Skip to main content Thank you for visiting nature.com. You are using a …